Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis

Area of Science:

• Microbiology
• Pharmacology
• Immunology

Background:

• Tuberculosis (TB) treatment relies on effective antibiotics like rifampicin.
• Understanding drug resistance mechanisms is crucial for combating TB.
• Somatic drug resistance can impact treatment efficacy.

Purpose of the Study:

• To investigate the development of somatic resistance to rifampicin in mice.
• To determine the effect of long-term rifampicin exposure on subsequent Mycobacterium tuberculosis infection.
• To assess the impact of treatment timing on rifampicin resistance.

Main Methods:

• Mice were exposed to rifampicin for six months.
• Mice were subsequently infected with Mycobacterium tuberculosis.
• The efficacy of rifampicin and isoniazid in suppressing bacterial growth was evaluated.
• The timing of rifampicin administration relative to infection was varied.

Main Results:

• Long-term rifampicin exposure induced resistance to rifampicin in mice, evidenced by impaired suppression of Mycobacterium tuberculosis growth in lungs and spleen.
• Isoniazid remained effective in these rifampicin-resistant mice.
• Somatic resistance to rifampicin was observed only when treatment commenced within 4 days post-infection.
• Resistance was not observed when rifampicin administration was delayed by 3 weeks after infection.

Conclusions:

• Long-term rifampicin administration can induce a specific somatic resistance in mice.
• Early intervention with rifampicin post-infection is critical for its efficacy.
• The timing of antibiotic administration significantly influences the development of drug resistance.